Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Preface - Emerging Viruses: From Early Detection to Intervention.

Identifieur interne : 000B66 ( PubMed/Checkpoint ); précédent : 000B65; suivant : 000B67

Preface - Emerging Viruses: From Early Detection to Intervention.

Auteurs : Giuseppe Ippolito [Italie] ; Giovanni Rezza [Italie]

Source :

RBID : pubmed:28364363

Descripteurs français

English descriptors

Abstract

In the last decades, several viruses emerged, as the consequence of cross-species passage from animal reservoirs to human being. Emerging infections always represent a significant challenge for public health system as knowledge about specific pathogens are generally little while and no/few effective interventions are available. In this volume we explored special aspects of emerging infectious diseases including: the application of the theory of focality of diseases to infective syndrome; the human-animal inter-face focusing on influenza; the role of bats as main reservoir of emerging and novel human pathogens; Middle East Respiratory Syndrome Coronavirus (MERS-CoV) epidemiology and clinical presentation; immediate impact on human health of the last Zika virus outbreak occurred in Pacific Ocean and the Americas; the role and potential application of animal models for the study of emerging infections, to improve disease knowledge and for developing therapeutic drugs during ongoing outbreak.

DOI: 10.1007/5584_2017_33
PubMed: 28364363


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28364363

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Preface - Emerging Viruses: From Early Detection to Intervention.</title>
<author>
<name sortKey="Ippolito, Giuseppe" sort="Ippolito, Giuseppe" uniqKey="Ippolito G" first="Giuseppe" last="Ippolito">Giuseppe Ippolito</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy. giuseppe.ippolito@inmi.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>National Institute for Infectious Diseases Lazzaro Spallanzani, Rome</wicri:regionArea>
<placeName>
<settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rezza, Giovanni" sort="Rezza, Giovanni" uniqKey="Rezza G" first="Giovanni" last="Rezza">Giovanni Rezza</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Infectious Diseases, Istituto Superiore di Sanità, Rome</wicri:regionArea>
<placeName>
<settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28364363</idno>
<idno type="pmid">28364363</idno>
<idno type="doi">10.1007/5584_2017_33</idno>
<idno type="wicri:Area/PubMed/Corpus">000D37</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D37</idno>
<idno type="wicri:Area/PubMed/Curation">000D37</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D37</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000B66</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B66</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Preface - Emerging Viruses: From Early Detection to Intervention.</title>
<author>
<name sortKey="Ippolito, Giuseppe" sort="Ippolito, Giuseppe" uniqKey="Ippolito G" first="Giuseppe" last="Ippolito">Giuseppe Ippolito</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy. giuseppe.ippolito@inmi.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>National Institute for Infectious Diseases Lazzaro Spallanzani, Rome</wicri:regionArea>
<placeName>
<settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rezza, Giovanni" sort="Rezza, Giovanni" uniqKey="Rezza G" first="Giovanni" last="Rezza">Giovanni Rezza</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Infectious Diseases, Istituto Superiore di Sanità, Rome</wicri:regionArea>
<placeName>
<settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Advances in experimental medicine and biology</title>
<idno type="ISSN">0065-2598</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Communicable Diseases, Emerging (virology)</term>
<term>Contact Tracing</term>
<term>Epidemiological Monitoring</term>
<term>Humans</term>
<term>Models, Biological</term>
<term>Viral Vaccines (immunology)</term>
<term>Virus Diseases (epidemiology)</term>
<term>Virus Diseases (prevention & control)</term>
<term>Virus Diseases (virology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Humains</term>
<term>Maladies transmissibles émergentes (virologie)</term>
<term>Maladies virales ()</term>
<term>Maladies virales (virologie)</term>
<term>Maladies virales (épidémiologie)</term>
<term>Modèles biologiques</term>
<term>Traçage des contacts</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Épidémiosurveillance</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Maladies transmissibles émergentes</term>
<term>Maladies virales</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Communicable Diseases, Emerging</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Maladies virales</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Contact Tracing</term>
<term>Epidemiological Monitoring</term>
<term>Humans</term>
<term>Models, Biological</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Humains</term>
<term>Maladies virales</term>
<term>Modèles biologiques</term>
<term>Traçage des contacts</term>
<term>Épidémiosurveillance</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In the last decades, several viruses emerged, as the consequence of cross-species passage from animal reservoirs to human being. Emerging infections always represent a significant challenge for public health system as knowledge about specific pathogens are generally little while and no/few effective interventions are available. In this volume we explored special aspects of emerging infectious diseases including: the application of the theory of focality of diseases to infective syndrome; the human-animal inter-face focusing on influenza; the role of bats as main reservoir of emerging and novel human pathogens; Middle East Respiratory Syndrome Coronavirus (MERS-CoV) epidemiology and clinical presentation; immediate impact on human health of the last Zika virus outbreak occurred in Pacific Ocean and the Americas; the role and potential application of animal models for the study of emerging infections, to improve disease knowledge and for developing therapeutic drugs during ongoing outbreak.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28364363</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0065-2598</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>972</Volume>
<PubDate>
<Year>2017</Year>
</PubDate>
</JournalIssue>
<Title>Advances in experimental medicine and biology</Title>
<ISOAbbreviation>Adv. Exp. Med. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Preface - Emerging Viruses: From Early Detection to Intervention.</ArticleTitle>
<Pagination>
<MedlinePgn>1-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/5584_2017_33</ELocationID>
<Abstract>
<AbstractText>In the last decades, several viruses emerged, as the consequence of cross-species passage from animal reservoirs to human being. Emerging infections always represent a significant challenge for public health system as knowledge about specific pathogens are generally little while and no/few effective interventions are available. In this volume we explored special aspects of emerging infectious diseases including: the application of the theory of focality of diseases to infective syndrome; the human-animal inter-face focusing on influenza; the role of bats as main reservoir of emerging and novel human pathogens; Middle East Respiratory Syndrome Coronavirus (MERS-CoV) epidemiology and clinical presentation; immediate impact on human health of the last Zika virus outbreak occurred in Pacific Ocean and the Americas; the role and potential application of animal models for the study of emerging infections, to improve disease knowledge and for developing therapeutic drugs during ongoing outbreak.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ippolito</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy. giuseppe.ippolito@inmi.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rezza</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Adv Exp Med Biol</MedlineTA>
<NlmUniqueID>0121103</NlmUniqueID>
<ISSNLinking>0065-2598</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016358" MajorTopicYN="N">Contact Tracing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Diagnostics</Keyword>
<Keyword MajorTopicYN="Y">Emergence</Keyword>
<Keyword MajorTopicYN="Y">Emerging infections</Keyword>
<Keyword MajorTopicYN="Y">Quarantine</Keyword>
<Keyword MajorTopicYN="Y">Vaccine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28364363</ArticleId>
<ArticleId IdType="doi">10.1007/5584_2017_33</ArticleId>
<ArticleId IdType="pmc">PMC7121201</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:103-122</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27864803</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:131-139</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28004307</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2014 Oct;14(10):1001-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25189351</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2013;9(7):e1003467</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23853589</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2014 Jun 14;383(9934):2073-2082</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24857703</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:7-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28213810</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2014 Sep 10;6(253):253ps10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25210060</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2014 Nov;14(11):1035-1037</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25444397</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2015 Jul 2;523(7558):35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26135440</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:49-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27966107</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:35-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27726073</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Opin Pulm Med. 2015 May;21(3):284-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25764021</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:87-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27722960</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:123-129</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28032326</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2012 Feb 2;366(5):454-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22296079</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Exp Med Biol. 2017;972:17-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27677275</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Italie</li>
</country>
<region>
<li>Latium</li>
</region>
<settlement>
<li>Rome</li>
</settlement>
</list>
<tree>
<country name="Italie">
<region name="Latium">
<name sortKey="Ippolito, Giuseppe" sort="Ippolito, Giuseppe" uniqKey="Ippolito G" first="Giuseppe" last="Ippolito">Giuseppe Ippolito</name>
</region>
<name sortKey="Rezza, Giovanni" sort="Rezza, Giovanni" uniqKey="Rezza G" first="Giovanni" last="Rezza">Giovanni Rezza</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B66 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000B66 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:28364363
   |texte=   Preface - Emerging Viruses: From Early Detection to Intervention.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:28364363" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021